Standout Papers

Empagliflozin in Heart Failure 2020 2026 2022 2024261
  1. Empagliflozin in Heart Failure (2020)
    Matthew D. Griffin, Veena S. Rao et al. Circulation

Immediate Impact

65 standout
Sub-graph 1 of 21

Citing Papers

New Insights into Endothelial Dysfunction in Cardiometabolic Diseases: Potential Mechanisms and Clinical Implications
2024 Standout
Semaglutide and cardiovascular outcomes in patients with obesity and prevalent heart failure: a prespecified analysis of the SELECT trial
2024 Standout
2 intermediate papers

Works of Devin Mahoney being referenced

Empagliflozin in Heart Failure
2020 Standout

Author Peers

Author Last Decade Papers Cites
Devin Mahoney 383 286 136 215 26 617
Juan B. Ivey‐Miranda 390 209 106 234 64 649
Ralph J. Riello 429 193 58 265 34 675
María Jesús Puchades 207 136 243 236 33 689
Eva M. Boorsma 437 236 90 348 11 714
Stephen J. Rooney 362 219 99 115 32 730
Hans Hillege 519 90 197 161 16 731
Christopher Maulion 256 162 68 223 30 713
Dale T. Ashby 247 124 121 111 29 636
Shunji Osaka 326 174 107 67 39 530
Calogero C. Tedesco 321 159 67 66 25 664

All Works

Loading papers...

Rankless by CCL
2026